Nancy E. Dempze’s AbbVie ABBV Stock Holding History

Nancy E. Dempze’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.59M	Sell	6,336 -350	-5%	-$75.3K	0.76%	37
2026 Q1	$1.45M	Sell	6,686 -5	-0.1%	-$1.11K	0.8%	35
2025 Q4	$1.53M	Buy	6,691 +1,192	+22%	+$272K	0.8%	36
2025 Q3	$1.27M	Sell	5,499 -356	-6%	-$72.5K	0.7%	41
2025 Q2	$1.09M	Sell	5,855 -856	-13%	-$159K	0.63%	42
2025 Q1	$1.41M	Sell	6,711 -111	-2%	-$21.6K	0.84%	35
2024 Q4	$1.21M	Sell	6,822 -70	-1%	-$12.9K	0.7%	42
2024 Q3	$1.36M	Buy	6,892 +5,112	+287%	+$954K	0.76%	41
2024 Q2	$305K	Buy	1,780 +667	+60%	+$110K	0.21%	64
2024 Q1	$203K	Buy	+1,113	New	+$192K	0.15%	61
2023 Q4	–	Sell	-1,498	Closed	-$223K	–	59
2023 Q3	$223K	Sell	1,498 -95	-6%	-$13.9K	0.2%	60
2023 Q2	$215K	Sell	1,593 -150	-9%	-$22K	0.18%	62
2023 Q1	$278K	Sell	1,743 -73	-4%	-$11.2K	0.25%	56
2022 Q4	$293K	Hold	1,816	–	–	0.29%	53
2022 Q3	$243K	Sell	1,816 -55	-3%	-$7.89K	0.26%	56
2022 Q2	$286K	Sell	1,871 -315	-14%	-$48.1K	0.29%	56
2022 Q1	$355K	Buy	2,186 +52	+2%	+$7.55K	0.26%	62
2021 Q4	$289K	Sell	2,134 -1,105	-34%	-$131K	0.2%	70
2021 Q3	$349K	Sell	3,239 -25	-0.8%	-$2.86K	0.27%	61
2021 Q2	$368K	Sell	3,264 -1,421	-30%	-$160K	0.31%	53
2021 Q1	$507K	Sell	4,685 -25	-0.5%	-$2.67K	0.45%	45
2020 Q4	$505K	Hold	4,710	–	–	0.46%	43
2020 Q3	$412K	Buy	4,710 +1,078	+30%	+$101K	0.42%	47
2020 Q2	$357K	Hold	3,632	–	–	0.4%	47
2020 Q1	$277K	Sell	3,632 -300	-8%	-$25.6K	0.37%	52
2019 Q4	$349K	Sell	3,932 -40	-1%	-$3.32K	0.39%	51
2019 Q3	$301K	Sell	3,972 -12	-0.3%	-$823	0.36%	52
2019 Q2	$290K	Hold	3,984	–	–	0.33%	53
2019 Q1	$321K	Hold	3,984	–	–	0.38%	52
2018 Q4	$368K	Sell	3,984 -407	-9%	-$35.8K	0.51%	44
2018 Q3	$416K	Sell	4,391 -9	-0.2%	-$853	0.47%	47
2018 Q2	$408K	Sell	4,400 -260	-6%	-$25.4K	0.5%	48
2018 Q1	$441K	Sell	4,660 -789	-14%	-$86.7K	0.54%	46
2017 Q4	$527K	Buy	5,449 +2,100	+63%	+$198K	0.64%	43
2017 Q3	$297K	Sell	3,349 -1,425	-30%	-$108K	0.42%	59
2017 Q2	$347K	Buy	4,774 +674	+16%	+$45.3K	0.5%	57
2017 Q1	$267K	Sell	4,100 -555	-12%	-$34.9K	0.41%	68
2016 Q4	$292K	Buy	4,655 +625	+16%	+$38.1K	0.51%	64
2016 Q3	$254K	Hold	4,030	–	–	0.44%	65
2016 Q2	$249K	Hold	4,030	–	–	0.44%	68
2016 Q1	$230K	Hold	4,030	–	–	0.4%	74
2015 Q4	$239K	Buy	+4,030	New	+$232K	0.46%	73

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Nancy E. Dempze's ABBV Position: Q2 2026 in Review

Nancy E. Dempze reduced its AbbVie (ABBV) stake by 5.2% in Q2 2026, selling an estimated $75.3K and leaving 6,336 shares worth $1.59M. The position accounts for 0.76% of the portfolio, ranked #37.

Nancy E. Dempze first reported a position in ABBV in Q4 2015 and has held it in 42 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Nancy E. Dempze held 6,336 shares of AbbVie worth $1.59M as of Q2 2026.
Nancy E. Dempze sold 350 AbbVie shares in Q2 2026, an estimated $75.3K.
AbbVie made up 0.76% of Nancy E. Dempze's portfolio in Q2 2026, its #37 holding.
Nancy E. Dempze first reported a position in AbbVie in Q4 2015 and has held it in 42 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Nancy E. Dempze's 13F filing for Q2 2026, filed 13 Aug 2026.